Industry: Chemical & Material
Published Date: 2025-01-18
Pages: 110 Pages
Report ld: 3439255
Request Sample
Customized Report
Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size(US$)

CAGR 2025-2031
5%
Market Size,2031
USD 1,209
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 863 million in 2024 and is forecast to a readjusted size of US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is experiencing steady growth, driven by its widespread application in the pharmaceutical, biotechnology, and personal care industries. PEG is valued for its versatility, biocompatibility, and non-toxicity, making it an essential component in a variety of drug formulations.
1. Growth in the Biopharmaceutical Sector
PEGylation: PEG is widely used in biopharmaceuticals through a process known as PEGylation, where PEG chains are attached to therapeutic molecules like proteins or peptides to enhance their stability, reduce immunogenicity, and extend their half-life. With the increasing development of biologics and biosimilars, the demand for PEG in these applications is rising.
Monoclonal Antibodies and Proteins: The growing use of monoclonal antibodies (mAbs) and therapeutic proteins in treating chronic diseases like cancer, autoimmune disorders, and genetic conditions is driving demand for PEG, which helps improve the pharmacokinetics of these drugs.
2. Increasing Application in Drug Delivery Systems
Oral, Injectable, and Topical Formulations: PEG is commonly used in various drug delivery systems, including oral, injectable, and topical formulations. Its solubility and ability to improve drug bioavailability make it a preferred excipient in many pharmaceutical products. The rising demand for innovative drug delivery systems is boosting the PEG market.
Controlled and Sustained Release Formulations: PEG is also used in controlled-release formulations to enhance drug stability and modulate the release of active ingredients. As the pharmaceutical industry focuses on developing long-acting formulations, the role of PEG in these systems is expanding.
4. Expansion in the Pharmaceutical Industry
Pharmaceutical Excipients: PEG serves as an important excipient in a wide range of pharmaceutical formulations, including tablets, capsules, and ointments. Its role in improving drug solubility and absorption is critical, particularly for poorly soluble drugs. The continued growth of the pharmaceutical industry, driven by an aging population and the rise in chronic diseases, is contributing to increased demand for pharmaceutical-grade PEG.
Over-the-Counter (OTC) Medications: PEG is commonly used in laxatives and stool softeners. With the increase in the prevalence of gastrointestinal issues and other digestive disorders, particularly in developed markets, the demand for PEG-based OTC medications is growing.
5. Growing Focus on Sustainable and Bio-Based PEG
Sustainability Initiatives: There is an increasing trend toward using bio-based PEG derived from renewable resources due to growing environmental concerns and regulations. Manufacturers are focusing on developing eco-friendly, sustainable alternatives to traditional petrochemical-based PEG, which is expected to gain traction in the pharmaceutical and personal care industries.
Regulatory Compliance: With the tightening of environmental and safety regulations in several regions, the focus on green chemistry and sustainable production methods is becoming more important. Companies investing in the production of bio-based or biodegradable PEG will benefit from this shift.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Polyethylene Glycol (PEG), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pharmaceutical Grade Polyethylene Glycol (PEG) by region & country, by Type, and by Application.
The Pharmaceutical Grade Polyethylene Glycol (PEG) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Polyethylene Glycol (PEG).
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Grade Polyethylene Glycol (PEG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pharmaceutical Grade Polyethylene Glycol (PEG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pharmaceutical Grade Polyethylene Glycol (PEG) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Product Introduction
1.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size Forecast
1.2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value (2020-2031)
1.2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume (2020-2031)
1.2.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Price (2020-2031)
1.3 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Trends & Drivers
1.3.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Industry Trends
1.3.2 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Drivers & Opportunity
1.3.3 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Challenges
1.3.4 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Players Revenue Ranking (2024)
2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue by Company (2020-2025)
2.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Players Sales Volume Ranking (2024)
2.4 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume by Company Players (2020-2025)
2.5 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Average Price by Company (2020-2025)
2.6 Key Manufacturers Pharmaceutical Grade Polyethylene Glycol (PEG) Manufacturing Base and Headquarters
2.7 Key Manufacturers Pharmaceutical Grade Polyethylene Glycol (PEG) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pharmaceutical Grade Polyethylene Glycol (PEG)
2.9 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Competitive Analysis
2.9.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Polyethylene Glycol (PEG) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Mw (<1000)
3.1.2 Mw (1000-10000)
3.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Type
3.2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, by Type (2020-2031)
3.2.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, by Type (%) (2020-2031)
3.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume by Type
3.3.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume, by Type (2020-2031)
3.3.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume, by Type (%) (2020-2031)
3.4 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablets
4.1.2 Capsules
4.1.3 Liquids
4.1.4 Injectables
4.1.5 Topicals
4.1.6 Others
4.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Application
4.2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, by Application (2020-2031)
4.2.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, by Application (%) (2020-2031)
4.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume by Application
4.3.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume, by Application (2020-2031)
4.3.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume, by Application (%) (2020-2031)
4.4 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Region
5.1.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Region (2020-2025)
5.1.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Region (2026-2031)
5.1.4 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Region (%), (2020-2031)
5.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume by Region
5.2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume by Region (2020-2025)
5.2.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume by Region (2026-2031)
5.2.4 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume by Region (%), (2020-2031)
5.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
5.4.2 North America Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
5.5.2 Europe Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
5.6.2 Asia Pacific Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
5.7.2 South America Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
5.8.2 Middle East & Africa Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value
6.2.1 Key Countries/Regions Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
6.3.2 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
6.4.2 Europe Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
6.5.2 China Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
6.6.2 Japan Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
6.7.2 South Korea Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
6.8.2 Southeast Asia Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value, 2020-2031
6.9.2 India Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 BASF
7.1.1 BASF Company Information
7.1.2 BASF Introduction and Business Overview
7.1.3 BASF Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 BASF Pharmaceutical Grade Polyethylene Glycol (PEG) Product Offerings
7.1.5 BASF Recent Development
7.2 Dow Chemical
7.2.1 Dow Chemical Company Information
7.2.2 Dow Chemical Introduction and Business Overview
7.2.3 Dow Chemical Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Dow Chemical Pharmaceutical Grade Polyethylene Glycol (PEG) Product Offerings
7.2.5 Dow Chemical Recent Development
7.3 Croda
7.3.1 Croda Company Information
7.3.2 Croda Introduction and Business Overview
7.3.3 Croda Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Croda Pharmaceutical Grade Polyethylene Glycol (PEG) Product Offerings
7.3.5 Croda Recent Development
7.4 Clariant
7.4.1 Clariant Company Information
7.4.2 Clariant Introduction and Business Overview
7.4.3 Clariant Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Clariant Pharmaceutical Grade Polyethylene Glycol (PEG) Product Offerings
7.4.5 Clariant Recent Development
7.5 Ineos
7.5.1 Ineos Company Information
7.5.2 Ineos Introduction and Business Overview
7.5.3 Ineos Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Ineos Pharmaceutical Grade Polyethylene Glycol (PEG) Product Offerings
7.5.5 Ineos Recent Development
7.6 India Glycols
7.6.1 India Glycols Company Information
7.6.2 India Glycols Introduction and Business Overview
7.6.3 India Glycols Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 India Glycols Pharmaceutical Grade Polyethylene Glycol (PEG) Product Offerings
7.6.5 India Glycols Recent Development
7.7 Shandong Ruisheng
7.7.1 Shandong Ruisheng Company Information
7.7.2 Shandong Ruisheng Introduction and Business Overview
7.7.3 Shandong Ruisheng Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Shandong Ruisheng Pharmaceutical Grade Polyethylene Glycol (PEG) Product Offerings
7.7.5 Shandong Ruisheng Recent Development
7.8 Jiangxi Yipusheng
7.8.1 Jiangxi Yipusheng Company Information
7.8.2 Jiangxi Yipusheng Introduction and Business Overview
7.8.3 Jiangxi Yipusheng Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Jiangxi Yipusheng Pharmaceutical Grade Polyethylene Glycol (PEG) Product Offerings
7.8.5 Jiangxi Yipusheng Recent Development
7.9 Liaoning Huaxing Chemical
7.9.1 Liaoning Huaxing Chemical Company Information
7.9.2 Liaoning Huaxing Chemical Introduction and Business Overview
7.9.3 Liaoning Huaxing Chemical Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Liaoning Huaxing Chemical Pharmaceutical Grade Polyethylene Glycol (PEG) Product Offerings
7.9.5 Liaoning Huaxing Chemical Recent Development
7.10 Petronas Chemicals
7.10.1 Petronas Chemicals Company Information
7.10.2 Petronas Chemicals Introduction and Business Overview
7.10.3 Petronas Chemicals Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Petronas Chemicals Pharmaceutical Grade Polyethylene Glycol (PEG) Product Offerings
7.10.5 Petronas Chemicals Recent Development
8 Industry Chain Analysis
8.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Industrial Chain
8.2 Pharmaceutical Grade Polyethylene Glycol (PEG) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Grade Polyethylene Glycol (PEG) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size was US$ 902 million in 2025 and is forecast to reach a readjusted size of US$ 1263 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market was valued at US$ 902 million in 2025 and is anticipated to reach US$ 1263 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 133
USD 2900.00
(Single User License)
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 902 million in 2025 and is projected to reach US$ 1263 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size was US$ 863 million in 2024 and is forecast to a readjusted size of US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 80
USD 4250.00
(Single User License)
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is projected to grow from US$ 863 million in 2024 to US$ 1209 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 136
USD 4900.00
(Single User License)
In 2024, the global market size of Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 863 million and is forecast to reach approximately US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 140
USD 5900.00
(Single User License)
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was valued at US$ 863 million in the year 2024 and is projected to reach a revised size of US$ 1209 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-18
Pages: 92
USD 2900.00
(Single User License)
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published Date: 2024-09-15
Pages: 119
USD 4350.00
(Single User License)
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published Date: 2024-09-15
Pages: 98
USD 3950.00
(Single User License)
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published Date: 2024-09-15
Pages: 136
USD 4900.00
(Single User License)
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size was US$ 902 million in 2025 and is forecast to reach a readjusted size of US$ 1263 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market was valued at US$ 902 million in 2025 and is anticipated to reach US$ 1263 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 133
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 902 million in 2025 and is projected to reach US$ 1263 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size was US$ 863 million in 2024 and is forecast to a readjusted size of US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 80
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is projected to grow from US$ 863 million in 2024 to US$ 1209 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 136
In 2024, the global market size of Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 863 million and is forecast to reach approximately US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 140
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was valued at US$ 863 million in the year 2024 and is projected to reach a revised size of US$ 1209 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-01-18
Pages: 92
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published: 2024-09-15
Pages: 119
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published: 2024-09-15
Pages: 98
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published: 2024-09-15
Pages: 136
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now